Ironwood Pharmaceuticals IRWD Business Segments
| FY'24 | FY'22 | ||
|---|---|---|---|
| Revenue by Product | |||
| Collaborative Arrangement Development And Commercialization Agreements | $2.24M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Ironwood Pharmaceuticals break its business down?
- Ironwood Pharmaceuticals (IRWD) reports revenue by product across 2 parts — Collaborative Arrangement Development And Commercialization Agreements and Royalty. Each is extracted from the segment footnotes and tracked over time.
- Where does Ironwood Pharmaceuticals's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Ironwood Pharmaceuticals's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
